Finance

Lists
Why is BHVN up ၄.၆၂%?
Dive Deeper
BHVN:NYSE
Biohaven Ltd
၁၁.၄၃ US$
+၄.၆၂%
(+၀.၅၁) 1D
၁၁.၃၀ US$
-၁.၁၄% (-၀.၁၃)
Pre-market
Closed: အောက် ၁၅, GMT-၄ ၁၆:၀၀:၀၃  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHVN...
Open
၁၀.၉၅ US$
High
၁၁.၆၆ US$
Low
၁၀.၉၄ US$
Mkt. cap
၁၇၂.၆၄ ဋေ
Avg. vol.
၂.၇၂ သန်း
Volume
၆.၈၇ ထောင်
52-wk high
၁၈.၅၇ US$
52-wk low
၇.၄၈ US$
EPS
-၄.၆၄ US$
Beta
၃.၁၉
Shares outstanding
၁၅.၁၀ ကုဋေ
No. of employees
၂၇၄
Open
၁၀.၉၅ US$
High
၁၁.၆၆ US$
Low
၁၀.၉၄ US$
Mkt. cap
၁၇၂.၆၄ ဋေ
Avg. vol.
၂.၇၂ သန်း
Volume
၆.၈၇ ထောင်
52-wk high
၁၈.၅၇ US$
52-wk low
၇.၄၈ US$
EPS
-၄.၆၄ US$
Beta
၃.၁၉
Shares outstanding
၁၅.၁၀ ကုဋေ
No. of employees
၂၇၄
News stories
From web sources and news partners
About Biohaven Ltd
CEO-
Employees၂၇၄
Founded၂၀၂၂
Headquartersနယူး ဟဲဗန်း, ကွန်​နက်​တီ​ကတ်​ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitebiohaven.com
Analyst ratings
Based on 11 analysts giving stock ratings to BHVN in the past 3 months
Buy
Buy
7
Hold
3
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for BHVN in the last 3 months.
Highest
Current ၁၁.၄၃ US$
၃၀.၀၀ US$ (+၁၆၂.၄၇%)
Average
၁၉.၆၃ US$ (+၇၁.၇၄%)
Lowest
၁၀.၀၀ US$ (-၁၂.၅၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
၁၁.၀၀ US$
-၃.၈%
10/12/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
၂၁.၀၀ US$
+၈၃.၇%
10/09/2026
Samantha Semenkow
Citi
Buy
Maintained
၁၇.၀၀ US$
+၄၈.၇%
09/17/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
09/13/2026
Douglas Tsao
H.C. Wainwright
Hold
Maintained
၁၀.၀၀ US$
-၁၂.၅%
09/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
-
-
09/10/2026
Myles Minter
William Blair
Hold
Reiterated
-
-
09/09/2026
Leonid Timashev
RBC Capital
Hold
Downgraded
၁၉.၀၀ US$
+၆၆.၂%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
၃၀.၀၀ US$
+၁၆၂.၅%
08/17/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
၁၉.၀၀ US$
+၆၆.၂%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
၃၀.၀၀ US$
+၁၆၂.၅%
08/11/2026
David Hoang
Deutsche Bank
Buy
Reiterated
၂၀.၀၀ US$
+၇၅%
06/26/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
၂၅.၀၀ US$
+၁၁၈.၇%
05/28/2026
Ashwani Verma
UBS
Hold
Reiterated
၁၁.၀၀ US$
-၃.၈%
05/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
၉.၀၀ US$
-၂၁.၃%
05/13/2026
Last report
၂၀၂၆ ဩ ၁၀
Fiscal period
Q2 2026
-၀.၇၈ US$ / -၀.၆၁ US$
-၂၇.၆၁%miss
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁၄.၁၂ ကုဋေ
၈.၄၉ ကုဋေ
၁၀.၃၈ ကုဋေ
၁၀.၀၈ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၈၂ ကုဋေ
၂.၀၈ ကုဋေ
၂.၆၆ ကုဋေ
၂.၄၁ ကုဋေ
Operating expense
၁၆.၉၄ ကုဋေ
၁၀.၅၇ ကုဋေ
၁၃.၀၄ ကုဋေ
၁၂.၄၉ ကုဋေ
Total operating expenses
၁၆.၉၄ ကုဋေ
၁၀.၅၇ ကုဋေ
၁၃.၀၄ ကုဋေ
၁၂.၄၉ ကုဋေ
Operating income
-၁၆.၉၄ ကုဋေ
-၁၀.၅၇ ကုဋေ
-၁၃.၀၄ ကုဋေ
-၁၂.၄၉ ကုဋေ
Other non operating income
-၇.၂၅ သန်း
-၅.၂၉ သန်း
-၃.၀၈ သန်း
-၁.၄၇ ကုဋေ
EBT including unusual items
-၁၇.၃၂ ကုဋေ
-၁၄.၅၂ ကုဋေ
-၁၃.၀၃ ကုဋေ
-၁၃.၆၉ ကုဋေ
EBT excluding unusual items
-၁၇.၆၆ ကုဋေ
-၁၁.၁၀ ကုဋေ
-၁၃.၃၅ ကုဋေ
-၁၃.၉၆ ကုဋေ
Income tax expense
၂.၂၁ သိန်း
၃.၅၁ သိန်း
၂.၇၂ သိန်း
၃.၉၁ သိန်း
Effective tax rate
-၀.၁၃%
-၀.၂၄%
-၀.၂၁%
-၀.၂၉%
Other operating expenses
-
-
-
-
Net income
-၁၇.၃၄ ကုဋေ
-၁၄.၅၆ ကုဋေ
-၁၃.၀၅ ကုဋေ
-၁၃.၇၃ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၄၇
-၀.၉၀
-၀.၆၉
-၀.၇၈
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁၆.၆၃ ကုဋေ
-၁၀.၃၂ ကုဋေ
-၁၂.၈၁ ကုဋေ
-၁၂.၂၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ